{"title":"Antibacterial Potential of Tetrahydrocarbazoles (THCZ): A Review","authors":"Nitin Kumar, Shalini Sharma, Saurabh Agrawal, Vishesh Verma","doi":"10.2174/0115734072275884240125100455","DOIUrl":null,"url":null,"abstract":"\n\nAntibiotic resistance has become a major public threat across the globe associated with\nhuman health. Some bacterial and fungal infections produce bacterial resistance, such as methicillin-\nresistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE)\nand multidrug-resistant (MDR) species Acinetobacter baumannii etc. Tetrahydrocarbazoles\n(THCz) are a sub-class of indole alkaloids profoundly present in natural products and biologically\nactive compounds and have displayed potential biological activities in literature. THCz exhibit\npotential antibacterial activities through major bacterial pathways like cell wall synthesis inhibition\nand DNA gyrase enzyme inhibition with DNA sliding clamp inhibitors and MreB inhibitors.\nThese THCZ also showed significant in vitro antibacterial activities against bacterial-resistant species,\nsuch as MRSA, VRE and Acinetobacter baumannii (MDR) in literature. MTDL (Multi Target\nDirect ligand) approach has been significantly used for the design of THC motif-based antibacterial\nagents. In this review article, we collected literature on THCz as a potential antibacterial\nagent from 2014 to date. The review study of THC core-based derivatives found excellent in vitro\nantibacterial profiles and revealed that they can play a significant role in drug discovery and the\ndevelopment of new antibiotics against various infectious diseases.\n","PeriodicalId":10772,"journal":{"name":"Current Bioactive Compounds","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioactive Compounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115734072275884240125100455","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Antibiotic resistance has become a major public threat across the globe associated with
human health. Some bacterial and fungal infections produce bacterial resistance, such as methicillin-
resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE)
and multidrug-resistant (MDR) species Acinetobacter baumannii etc. Tetrahydrocarbazoles
(THCz) are a sub-class of indole alkaloids profoundly present in natural products and biologically
active compounds and have displayed potential biological activities in literature. THCz exhibit
potential antibacterial activities through major bacterial pathways like cell wall synthesis inhibition
and DNA gyrase enzyme inhibition with DNA sliding clamp inhibitors and MreB inhibitors.
These THCZ also showed significant in vitro antibacterial activities against bacterial-resistant species,
such as MRSA, VRE and Acinetobacter baumannii (MDR) in literature. MTDL (Multi Target
Direct ligand) approach has been significantly used for the design of THC motif-based antibacterial
agents. In this review article, we collected literature on THCz as a potential antibacterial
agent from 2014 to date. The review study of THC core-based derivatives found excellent in vitro
antibacterial profiles and revealed that they can play a significant role in drug discovery and the
development of new antibiotics against various infectious diseases.
Current Bioactive CompoundsPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.90
自引率
0.00%
发文量
112
期刊介绍:
The journal aims to provide comprehensive review articles on new bioactive compounds with proven activities in various biological screenings and pharmacological models with a special emphasis on stereoeselective synthesis. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia. The journal should prove to be essential reading for pharmacologists, natural product chemists and medicinal chemists who wish to be kept informed and up-to-date with the most important developments on new bioactive compounds of natural or synthetic origin, including their stereoeselective synthesis.